Correlation Between Virpax Pharmaceuticals and Sasol

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Sasol at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Sasol into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Sasol, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Sasol and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Sasol. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Sasol.

Diversification Opportunities for Virpax Pharmaceuticals and Sasol

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Virpax and Sasol is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Sasol in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sasol and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Sasol. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sasol has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Sasol go up and down completely randomly.

Pair Corralation between Virpax Pharmaceuticals and Sasol

Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to generate 10.7 times more return on investment than Sasol. However, Virpax Pharmaceuticals is 10.7 times more volatile than Sasol. It trades about 0.04 of its potential returns per unit of risk. Sasol is currently generating about 0.03 per unit of risk. If you would invest  33.00  in Virpax Pharmaceuticals on July 20, 2025 and sell it today you would lose (31.90) from holding Virpax Pharmaceuticals or give up 96.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Virpax Pharmaceuticals  vs.  Sasol

 Performance 
       Timeline  
Virpax Pharmaceuticals 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Virpax Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Virpax Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Sasol 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sasol are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Sasol is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Virpax Pharmaceuticals and Sasol Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virpax Pharmaceuticals and Sasol

The main advantage of trading using opposite Virpax Pharmaceuticals and Sasol positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Sasol can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sasol will offset losses from the drop in Sasol's long position.
The idea behind Virpax Pharmaceuticals and Sasol pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes